Xing Yang

609 total citations · 1 hit paper
37 papers, 357 citations indexed

About

Xing Yang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Xing Yang has authored 37 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Xing Yang's work include Cancer Immunotherapy and Biomarkers (6 papers), Glioma Diagnosis and Treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Xing Yang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Glioma Diagnosis and Treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Xing Yang collaborates with scholars based in China, Germany and United Kingdom. Xing Yang's co-authors include Rui Guo, Hong Wang, Ziling Liu, Kejian Guo, Jie Gao, Feng Wu, Liqin Zhou, Jianfang Zhang, Min Zhang and Xiaoman Li and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Experimental Neurology.

In The Last Decade

Xing Yang

32 papers receiving 351 citations

Hit Papers

Immunotherapy: a promising approach for glioma treatment 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xing Yang China 10 106 86 74 64 57 37 357
Dionne Davis United States 8 73 0.7× 147 1.7× 172 2.3× 100 1.6× 110 1.9× 10 472
Marsha-Kay Hutchinson United States 5 88 0.8× 152 1.8× 217 2.9× 85 1.3× 117 2.1× 5 492
Qi Yu China 13 73 0.7× 176 2.0× 82 1.1× 93 1.5× 73 1.3× 37 540
Caitlin Marie Reid United States 4 69 0.7× 116 1.3× 234 3.2× 87 1.4× 174 3.1× 5 479
Haining Li China 11 110 1.0× 237 2.8× 141 1.9× 36 0.6× 149 2.6× 22 482
Heather M. Sonnemann United States 4 57 0.5× 81 0.9× 183 2.5× 83 1.3× 130 2.3× 7 384
Xiaolei Hao China 13 33 0.3× 125 1.5× 101 1.4× 38 0.6× 277 4.9× 28 573
Kerry L. Sanders United States 12 124 1.2× 148 1.7× 74 1.0× 11 0.2× 52 0.9× 17 362
Yongxin Ru China 13 38 0.4× 163 1.9× 55 0.7× 44 0.7× 136 2.4× 41 448

Countries citing papers authored by Xing Yang

Since Specialization
Citations

This map shows the geographic impact of Xing Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Yang more than expected).

Fields of papers citing papers by Xing Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Yang. The network helps show where Xing Yang may publish in the future.

Co-authorship network of co-authors of Xing Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xing Yang. A scholar is included among the top collaborators of Xing Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Yang. Xing Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Duan, Dongzhu, Xing Yang, Mi Li, et al.. (2025). Interaction of glaucocalyxin a with glutathione and thioredoxin reductase for triple-negative breast cancer treatment. Bioorganic Chemistry. 161. 108572–108572. 7 indexed citations
3.
Tan, Wenfeng, Siyuan Qin, Xing Yang, et al.. (2025). Global Prevalence and Distribution of H9 Subtype of Avian Influenza Viruses in Wild Birds: Literature Review with Meta-Analysis. Vector-Borne and Zoonotic Diseases. 25(5). 346–358. 2 indexed citations
4.
Liu, Shuo, Miao Zhang, Haitao Wang, et al.. (2025). Prevalence and assemblage distribution of Giardia intestinalis in farmed mink, foxes, and raccoon dogs in northern China. Frontiers in Veterinary Science. 12. 1514525–1514525.
5.
Ma, Jingwei, Yang Yang, Caixia Zang, et al.. (2025). Inhibiting mitochondrial excessive fission alleviates the neuronal damage in Parkinson's disease via regulating PGC-1α mediated mitochondrial biogenesis. Experimental Neurology. 391. 115288–115288. 3 indexed citations
6.
Jiang, Yueqi, Yang Yang, Caixia Zang, et al.. (2025). Gut microbial dysbiosis aggravated Parkinson-like pathology induced by MPTP/probenecid. Physiology & Behavior. 299. 115008–115008. 1 indexed citations
7.
Li, Zhong-Yuan, Haitao Wang, Xuemin Li, et al.. (2024). High genetic diversity of Enterocytozoon bieneusi in minks and raccoon dogs in northern China. Parasite. 31. 71–71. 1 indexed citations
8.
Wang, Yanchun, Xiaoman Li, Xing Yang, et al.. (2024). Global prevalence and risk factors of Enterocytozoon bieneusi infection in humans: a systematic review and meta-analysis. Parasite. 31. 9–9. 17 indexed citations
9.
Zhang, Meng, Si–Yi Chen, Yaonan Li, et al.. (2024). Antibody–drug conjugates in urothelial carcinoma: scientometric analysis and clinical trials analysis. Frontiers in Oncology. 14. 1323366–1323366. 2 indexed citations
10.
Yang, Xing, et al.. (2024). Genistein-Chitosan Derivative Nanoparticles for Targeting and Enhancing the Anti-Breast Cancer Effect of Tamoxifen In Vitro. Journal of Pharmaceutical Sciences. 113(8). 2575–2583. 8 indexed citations
11.
Li, Zhiyi, Xing Yang, Lei Yang, et al.. (2024). Antibody–drug conjugates for breast cancer: a bibliometric study and clinical trial analysis. Discover Oncology. 15(1). 329–329. 4 indexed citations
12.
Yang, Xing, et al.. (2024). A scientometric analysis of immunotherapies for gliomas: Focus on GBM. Asian Journal of Surgery. 47(10). 4271–4280. 3 indexed citations
14.
Yang, Xing, Mei Yang, Yajie Du, et al.. (2023). A scientometric analysis and up-to-date review of nano-based drug delivery systems in glioblastoma treatment. Nano Today. 52. 101961–101961. 16 indexed citations
15.
Wang, Yanchun, Jinghao Li, Siyuan Qin, et al.. (2023). The Prevalence of Rodents Orientia tsutsugamushi in China During Two Decades: A Systematic Review and Meta-Analysis. Vector-Borne and Zoonotic Diseases. 23(12). 619–633. 1 indexed citations
16.
Xie, Bin, et al.. (2023). Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023). World Journal of Gastroenterology. 29(40). 5593–5617. 6 indexed citations
17.
Wang, Yujun, Xing Yang, Qiushi Wang, et al.. (2023). The Swin-Transformer network based on focal loss is used to identify images of pathological subtypes of lung adenocarcinoma with high similarity and class imbalance. Journal of Cancer Research and Clinical Oncology. 149(11). 8581–8592. 15 indexed citations
18.
Yang, Xing, Yajie Du, Ying Zhang, et al.. (2023). Immunotherapy in cervical cancer: From the view of scientometric analysis and clinical trials. Frontiers in Immunology. 14. 1094437–1094437. 11 indexed citations
19.
Shi, Jingwei, et al.. (2022). JNK inhibitor IX restrains pancreatic cancer through p53 and p21. Frontiers in Oncology. 12. 1006131–1006131. 5 indexed citations
20.
Yang, Xing & Kejian Guo. (2013). Bronchogenic cyst of stomach: two cases report and review of the English literature. Wiener klinische Wochenschrift. 125(9-10). 283–287. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026